Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review.

Edahiro Y, Yasuda H, Ando K, Komatsu N.

Int J Hematol. 2019 Dec 9. doi: 10.1007/s12185-019-02792-x. [Epub ahead of print]

PMID:
31820325
2.

Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface.

Masubuchi N, Araki M, Yang Y, Hayashi E, Imai M, Edahiro Y, Hironaka Y, Mizukami Y, Kihara Y, Takei H, Nudejima M, Koike M, Ohsaka A, Komatsu N.

Leukemia. 2019 Aug 28. doi: 10.1038/s41375-019-0564-z. [Epub ahead of print]

PMID:
31462733
3.

JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera.

Inano T, Araki M, Morishita S, Imai M, Yasuda H, Nitta H, Ito M, Edahiro Y, Ochiai T, Misawa K, Fukuda Y, Ohsaka A, Komatsu N.

Br J Haematol. 2019 Oct;187(1):e27-e31. doi: 10.1111/bjh.16146. Epub 2019 Aug 16. No abstract available.

PMID:
31418453
4.

[Efficacy and safety of ruxolitinib in patients with myelofibrosis: a single-center retrospective analysis].

Edahiro Y, Komatsu N.

Rinsho Ketsueki. 2019;60(7):755-760. doi: 10.11406/rinketsu.60.755. Japanese.

PMID:
31391362
5.

Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review.

Sugiyama M, Ueno Y, Kamo H, Edahiro Y, Miyamoto N, Yamashiro K, Tanaka R, Shimo Y, Komatsu N, Hattori N.

J Neurol. 2019 Aug;266(8):1869-1878. doi: 10.1007/s00415-019-09347-4. Epub 2019 May 2.

PMID:
31049728
6.

Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.

Edahiro Y, Araki M, Inano T, Ito M, Morishita S, Misawa K, Fukuda Y, Imai M, Ohsaka A, Komatsu N.

Eur J Haematol. 2019 Jun;102(6):516-520. doi: 10.1111/ejh.13236. Epub 2019 Apr 25.

PMID:
30977935
7.

Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy.

Fukuda Y, Araki M, Yamamoto K, Morishita S, Inano T, Misawa K, Ochiai T, Edahiro Y, Imai M, Yasuda H, Gotoh A, Ohsaka A, Komatsu N.

Haematologica. 2019 Nov;104(11):e506-e509. doi: 10.3324/haematol.2018.208876. Epub 2019 Apr 4. No abstract available.

8.

Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome.

Sasaki R, Horimoto Y, Mizuno J, Edahiro Y, Ohmori T, Komatsu N, Saito M.

Surg Case Rep. 2018 Sep 17;4(1):118. doi: 10.1186/s40792-018-0528-y.

9.

Multiple Placental Infarcts in a Pregnant Woman with Essential Thrombocythemia.

Edahiro Y, Ando J, Suzuki T, Fukumura Y, Masuda A, Sakayori S, Takeda J, Maruyama Y, Makino S, Itakura A, Komatsu N.

Intern Med. 2018 Dec 15;57(24):3647-3650. doi: 10.2169/internalmedicine.1311-18. Epub 2018 Aug 10.

10.

Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation.

Araki M, Yang Y, Imai M, Mizukami Y, Kihara Y, Sunami Y, Masubuchi N, Edahiro Y, Hironaka Y, Osaga S, Ohsaka A, Komatsu N.

Leukemia. 2019 Jan;33(1):122-131. doi: 10.1038/s41375-018-0181-2. Epub 2018 Jun 26.

PMID:
29946189
11.

Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations.

Takei H, Edahiro Y, Mano S, Masubuchi N, Mizukami Y, Imai M, Morishita S, Misawa K, Ochiai T, Tsuneda S, Endo H, Nakamura S, Eto K, Ohsaka A, Araki M, Komatsu N.

Br J Haematol. 2018 Jun;181(6):791-802. doi: 10.1111/bjh.15266. Epub 2018 May 9.

PMID:
29741776
12.

[Transfusion independence achieved with pomalidomide therapy in a patient with primary myelofibrosis].

Edahiro Y, Gotoh A, Inano T, Tsutsui M, Tsukune Y, Yasuda H, Komatsu N.

Rinsho Ketsueki. 2018;59(3):323-325. doi: 10.11406/rinketsu.59.323. Japanese.

PMID:
29618692
13.

Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.

Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.

Int J Hematol. 2018 Jun;107(6):673-680. doi: 10.1007/s12185-018-2421-7. Epub 2018 Feb 20.

PMID:
29464483
14.

The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.

Ochiai T, Yasuda H, Araki M, Misawa K, Morishita S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.

Eur J Haematol. 2018 Jun;100(6):544-549. doi: 10.1111/ejh.13041. Epub 2018 Apr 2.

PMID:
29405428
15.

[Chronic myeloid leukemia complicated by pulmonary hypertension during dasatinib therapy: a single-center retrospective study].

Edahiro Y, Takaku T, Konishi H, Tsukune Y, Fujioka I, Takasu K, Gotoh A, Daida H, Komatsu N.

Rinsho Ketsueki. 2017;58(11):2213-2218. doi: 10.11406/rinketsu.58.2213. Japanese.

PMID:
29212971
16.

The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera: Comparison with the 2008 WHO diagnostic criteria.

Misawa K, Yasuda H, Araki M, Ochiai T, Morishita S, Nudejima M, Hironaka Y, Shirane S, Edahiro Y, Gotoh A, Ohsaka A, Komatsu N.

Am J Hematol. 2017 Jul;92(7):E128-E130. doi: 10.1002/ajh.24752. Epub 2017 May 26. No abstract available.

17.

Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.

Ichikawa K, Edahiro Y, Gotoh A, Iiduka K, Komatsu N, Koike M.

Int J Hematol. 2016 Nov;104(5):612-620. Epub 2016 Jul 25.

PMID:
27456463
18.

[Chronic Myelomonocytic Leukemia with Myelofibrosis Resulting in Sudden Massive Pleural Effusion during Cytoreductive Therapy with Hydroxycarbamide].

Sunami Y, Gotoh A, Watanabe N, Edahiro Y, Hamano Y, Harada H, Komatsu N.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1223-1226. Japanese.

PMID:
27760943
19.

Successful perioperative management of factor XI deficiency with administration of fresh-frozen plasma in a subdural hematoma patient.

Edahiro Y, Ichikawa K, Suzuki H, Yasuda H, Koike M, Komatsu N.

Geriatr Gerontol Int. 2016 Jan;16(1):143-4. doi: 10.1111/ggi.12512. No abstract available.

PMID:
26974602
20.

Identification of AIM2 as a downstream target of JAK2V617F.

Liew EL, Araki M, Hironaka Y, Mori S, Tan TZ, Morishita S, Edahiro Y, Ohsaka A, Komatsu N.

Exp Hematol Oncol. 2016 Jan 28;5:2. doi: 10.1186/s40164-016-0032-7. eCollection 2015.

21.

Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.

Araki M, Yang Y, Masubuchi N, Hironaka Y, Takei H, Morishita S, Mizukami Y, Kan S, Shirane S, Edahiro Y, Sunami Y, Ohsaka A, Komatsu N.

Blood. 2016 Mar 10;127(10):1307-16. doi: 10.1182/blood-2015-09-671172. Epub 2016 Jan 27.

PMID:
26817954
22.

[Autoimmune hemolytic anemia in a patient with TAFRO syndrome].

Edahiro Y, Ichikawa K, Sunami Y, Koike M, Komatsu N.

Rinsho Ketsueki. 2015 Nov;56(11):2346-50. doi: 10.11406/rinketsu.56.2346. Japanese.

PMID:
26666723
23.

Impact of non-dipping on cardiovascular outcomes in patients with obstructive sleep apnea syndrome.

Sasaki N, Ozono R, Edahiro Y, Ishii K, Seto A, Okita T, Teramen K, Fujiwara S, Kihara Y.

Clin Exp Hypertens. 2015;37(6):449-53. doi: 10.3109/10641963.2015.1057833.

PMID:
26395950
24.

[Application of genetic data to clinical practice of MPN].

Edahiro Y.

Rinsho Ketsueki. 2015 Aug;56(8):949-55. doi: 10.11406/rinketsu.56.949. Japanese.

PMID:
26345552
25.

[Current problems in the diagnosis of Philadelphia-negative myeloproliferative neoplasms in Japan].

Shirane S, Araki M, Morishita S, Edahiro Y, Ohsaka A, Komatsu N.

Rinsho Ketsueki. 2015 Jul;56(7):877-82. doi: 10.11406/rinketsu.56.877. Japanese.

PMID:
26251152
26.

Various neurological symptoms by neurolymphomatosis as the initial presentation of primary testicular lymphoma.

Sunami Y, Gotoh A, Hamano Y, Yahata Y, Sakurai H, Shirane S, Edahiro Y, Komatsu N.

Case Rep Oncol. 2015 Apr 24;8(1):200-4. doi: 10.1159/000381874. eCollection 2015 Jan-Apr.

27.

Melting curve analysis after T allele enrichment (MelcaTle) as a highly sensitive and reliable method for detecting the JAK2V617F mutation.

Morishita S, Takahashi K, Araki M, Hironaka Y, Sunami Y, Edahiro Y, Tsutsui M, Ohsaka A, Tsuneda S, Komatsu N.

PLoS One. 2015 Mar 20;10(3):e0122003. doi: 10.1371/journal.pone.0122003. eCollection 2015.

28.

Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemia.

Shirane S, Araki M, Morishita S, Edahiro Y, Sunami Y, Hironaka Y, Noguchi M, Koike M, Sato E, Ohsaka A, Komatsu N.

Int J Hematol. 2015 Feb;101(2):148-53. doi: 10.1007/s12185-014-1721-9. Epub 2014 Dec 19.

PMID:
25522845
29.

JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms.

Shirane S, Araki M, Morishita S, Edahiro Y, Takei H, Yoo Y, Choi M, Sunami Y, Hironaka Y, Noguchi M, Koike M, Noda N, Ohsaka A, Komatsu N.

Haematologica. 2015 Feb;100(2):e46-8. doi: 10.3324/haematol.2014.115113. Epub 2014 Nov 14. No abstract available.

30.

Detection of MPLW515L/K mutations and determination of allele frequencies with a single-tube PCR assay.

Takei H, Morishita S, Araki M, Edahiro Y, Sunami Y, Hironaka Y, Noda N, Sekiguchi Y, Tsuneda S, Ohsaka A, Komatsu N.

PLoS One. 2014 Aug 21;9(8):e104958. doi: 10.1371/journal.pone.0104958. eCollection 2014. Erratum in: PLoS One. 2015;10(4):e0124208.

31.

JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.

Edahiro Y, Morishita S, Takahashi K, Hironaka Y, Yahata Y, Sunami Y, Shirane S, Tsutsui M, Noguchi M, Koike M, Imai K, Kirito K, Noda N, Sekiguchi Y, Tsuneda S, Ohsaka A, Araki M, Komatsu N.

Int J Hematol. 2014;99(5):625-34. doi: 10.1007/s12185-014-1567-1. Epub 2014 Mar 28.

PMID:
24677207
32.

The relationship between morning hypertension and sleep quality in patients with obstructive sleep apnea syndrome.

Sasaki N, Ozono R, Yamauchi R, Teramen K, Edahiro Y, Ishii K, Seto A, Kihara Y.

Clin Exp Hypertens. 2013;35(4):250-6. doi: 10.3109/10641963.2013.780069. Epub 2013 Mar 26.

PMID:
23530964
33.

Inhibition of the NAD-dependent protein deacetylase SIRT2 induces granulocytic differentiation in human leukemia cells.

Sunami Y, Araki M, Hironaka Y, Morishita S, Kobayashi M, Liew EL, Edahiro Y, Tsutsui M, Ohsaka A, Komatsu N.

PLoS One. 2013;8(2):e57633. doi: 10.1371/journal.pone.0057633. Epub 2013 Feb 27.

34.

Age-related differences in the mechanism of nondipping among patients with obstructive sleep apnea syndrome.

Sasaki N, Ozono R, Yamauchi R, Teramen K, Munemori M, Hamada H, Edahiro Y, Ishii K, Seto A, Kihara Y.

Clin Exp Hypertens. 2012;34(4):270-7. doi: 10.3109/10641963.2012.681083. Epub 2012 May 4.

PMID:
22559060

Supplemental Content

Loading ...
Support Center